摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[4-(2,5-dimethylpyrrol-1-yl)-2-trifluoromethyl-benzyl]-pyridine | 863676-16-8

中文名称
——
中文别名
——
英文名称
4-[4-(2,5-dimethylpyrrol-1-yl)-2-trifluoromethyl-benzyl]-pyridine
英文别名
4-[4-(2,5-Dimethyl-pyrrol-1-yl)-2-trifluoromethyl-benzyl]-pyridine;4-[[4-(2,5-dimethylpyrrol-1-yl)-2-(trifluoromethyl)phenyl]methyl]pyridine
4-[4-(2,5-dimethylpyrrol-1-yl)-2-trifluoromethyl-benzyl]-pyridine化学式
CAS
863676-16-8
化学式
C19H17F3N2
mdl
——
分子量
330.353
InChiKey
YONYPACVRVIBCQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    17.8
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Heteroarylphenylurea Derivative
    申请人:Oikawa Nobuhiro
    公开号:US20080119466A1
    公开(公告)日:2008-05-22
    The present invention provides a compound represented by the formula (1): wherein R 1 , R 2 and R 5 are each independently selected from a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl is substituted with a halogen atom and the like; R 3 and R 4 are each independently selected from a hydrogen atom, a halogen atom, a substituted C 1 -C 6 alkyl group and the like; R 6 and R 7 are each independently selected from a hydrogen atom and a halogen atom; Z 1 and Z 2 are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR 11 )OC(═O)R 12 ; Q is a group of the formula: (wherein G 1 is C—Y 2 or N; a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle) a pharmaceutically acceptable salt thereof or a prodrug thereof.
    本发明提供了一种由式(1)表示的化合物:其中,R1、R2和R5分别独立地选自氢原子、卤原子、C1-C6烷基被卤原子等取代基;R3和R4分别独立地选自氢原子、卤原子、取代的C1-C6烷基等基团;R6和R7分别独立地选自氢原子和卤原子;Z1和Z2分别独立地选自氢原子、羟基和—O(CHR11)OC(═O)R12;Q是下式的基团:(其中,G1是C—Y2或N;环A是苯环或5-至6-成员的不饱和杂环);其药学上可接受的盐或前药。
  • Heteroarylphenylurea derivative
    申请人:Oikawa Nobuhiro
    公开号:US08609656B2
    公开(公告)日:2013-12-17
    The present invention provides a compound represented by the formula (1): wherein R1, R2 and R5 are each independently selected from a hydrogen atom, a halogen atom, a C1-C6 alkyl is substituted with a halogen atom and the like; R3 and R4 are each independently selected from a hydrogen atom, a halogen atom, a substituted C1-C6 alkyl group and the like; R6 and R7 are each independently selected from a hydrogen atom and a halogen atom; Z1 and Z2 are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR11)OC(═O)R12; Q is a group of the formula: (wherein G1 is C—Y2 or N; a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle) a pharmaceutically acceptable salt thereof or a prodrug thereof.
    本发明提供一种化合物,其表示为式(1): 其中,R1、R2和R5各自独立地选择自氢原子、卤素原子、C1-C6烷基被卤素原子等取代基;R3和R4各自独立地选择自氢原子、卤素原子、取代的C1-C6烷基等;R6和R7各自独立地选择自氢原子和卤素原子;Z1和Z2各自独立地选择自氢原子、羟基和—O(CHR11)OC(═O)R12;Q是下式的基团:(其中,G1是C—Y2或N;环A是苯环或5-至6-成员不饱和杂环);其药学上可接受的盐或其前药。
  • US8609656B2
    申请人:——
    公开号:US8609656B2
    公开(公告)日:2013-12-17
  • HETEROARYLPHENYLUREA DERIVATIVE
    申请人:CHUGAI SEIYAKU KABUSHIKI KAISHA
    公开号:EP1724258B1
    公开(公告)日:2012-04-11
查看更多